Incontinence: How Do β-adrenoceptor Agonists Work in the Bladder?

Overview

Journal Nat Rev Urol

Specialty Urology

Date 2017 Mar 22

PMID 28322259

Citations 3

Authors

Yasuhiko Igawa

Naoki Aizawa

Affiliations

Soon will be listed here.

Citing Articles

β Relaxant Effect in Human Bladder Involves Cystathionine γ-Lyase-Derived Urothelial Hydrogen Sulfide.

Mitidieri E, Pecoraro A, Esposito E, Brancaleone V, Turnaturi C, Napolitano L Antioxidants (Basel). 2022; 11(8).

PMID: 36009199 PMC: 9405273. DOI: 10.3390/antiox11081480.

Pharmacology of the lower urinary tract: update on LUTS treatment.

Abreu-Mendes P, Silva J, Cruz F Ther Adv Urol. 2020; 12:1756287220922425.

PMID: 32489425 PMC: 7238773. DOI: 10.1177/1756287220922425.

β Adrenoceptor-induced cholinergic inhibition in human and rat urinary bladders involves the exchange protein directly activated by cyclic AMP 1 favoring adenosine release.

Silva I, Magalhaes-Cardoso M, Ferreirinha F, Moreira S, Costa A, Silva D Br J Pharmacol. 2019; 177(7):1589-1608.

PMID: 31721163 PMC: 7060368. DOI: 10.1111/bph.14921.

References

Cernecka H, Ochodnicky P, Lamers W, Michel M . Specificity evaluation of antibodies against human β3-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol. 2012; 385(9):875-82. DOI: 10.1007/s00210-012-0767-6. View

Limberg B, Andersson K, Kullmann F, Burmer G, de Groat W, Rosenbaum J . β-Adrenergic receptor subtype expression in myocyte and non-myocyte cells in human female bladder. Cell Tissue Res. 2010; 342(2):295-306. PMC: 3113530. DOI: 10.1007/s00441-010-1053-x. View

Nitti V, Rosenberg S, Mitcheson D, He W, Fakhoury A, Martin N . Urodynamics and safety of the β₃-adrenoceptor agonist mirabegron in males with lower urinary tract symptoms and bladder outlet obstruction. J Urol. 2013; 190(4):1320-7. DOI: 10.1016/j.juro.2013.05.062. View

Takasu T, Ukai M, Sato S, Matsui T, Nagase I, Maruyama T . Effect of (R)-2-(2-aminothiazol-4-yl)-4'-{2-[(2-hydroxy-2-phenylethyl)amino]ethyl} acetanilide (YM178), a novel selective beta3-adrenoceptor agonist, on bladder function. J Pharmacol Exp Ther. 2007; 321(2):642-7. DOI: 10.1124/jpet.106.115840. View

Aizawa N, Homma Y, Igawa Y . Effects of mirabegron, a novel β3-adrenoceptor agonist, on primary bladder afferent activity and bladder microcontractions in rats compared with the effects of oxybutynin. Eur Urol. 2012; 62(6):1165-73. DOI: 10.1016/j.eururo.2012.08.056. View

Coelho A, Antunes-Lopes T, Gillespie J, Cruz F . Beta-3 adrenergic receptor is expressed in acetylcholine-containing nerve fibers of the human urinary bladder: An immunohistochemical study. Neurourol Urodyn. 2017; 36(8):1972-1980. DOI: 10.1002/nau.23224. View

Vahabi B, Drake M . Physiological and pathophysiological implications of micromotion activity in urinary bladder function. Acta Physiol (Oxf). 2014; 213(2):360-70. DOI: 10.1111/apha.12373. View

Drake M, Harvey I, Gillespie J, van Duyl W . Localized contractions in the normal human bladder and in urinary urgency. BJU Int. 2005; 95(7):1002-5. DOI: 10.1111/j.1464-410X.2005.05455.x. View

Drake M, Chapple C, Esen A, Athanasiou S, Cambronero J, Mitcheson D . Efficacy and Safety of Mirabegron Add-on Therapy to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Initial 4-Week Solifenacin Monotherapy: A Randomised Double-blind Multicentre Phase 3B Study (BESIDE). Eur Urol. 2016; 70(1):136-145. DOI: 10.1016/j.eururo.2016.02.030. View

10.

Rouget C, Rekik M, Camparo P, Botto H, Rischmann P, Lluel P . Modulation of nerve-evoked contractions by β3-adrenoceptor agonism in human and rat isolated urinary bladder. Pharmacol Res. 2014; 80:14-20. DOI: 10.1016/j.phrs.2013.12.006. View